Biodesix, Inc. (BDSX)

NGM – Цена в реальном времени. Валюта: USD

15.75

-0.36 (-2.23%)

При закрытии: May 12, 2026, 4:00 PM EDT

15.94

+0.19 (1.21%)

До открытия: May 13, 2026, 6:05 AM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Biodesix, Inc. (BDSX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Biodesix, Inc. (BDSX)

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

Biodesix Announces First Quarter 2026 Results and Highlights

Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Видео

No Data

Пресс-релизы

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix Announces First Quarter 2026 Results and Highlights

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

Search stocks

Biodesix, Inc. (BDSX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Biodesix, Inc. (BDSX)

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

Biodesix Announces First Quarter 2026 Results and Highlights

Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Видео

No Data

Пресс-релизы

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix Announces First Quarter 2026 Results and Highlights

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development